Angiogenic factors and preeclampsia

Frontiers in Bioscience

Volumn 12, Issue 7, 2007, Pages 2395-2402

  Tjoa, May Lee ^a   Levine, Richard J ^b   Karumanchi, S Ananth ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Angiogenesis; Angiogenic growth factors; Preeclampsia; Soluble endoglin; Soluble Flt1

Indexed keywords

ANGIOGENIC PROTEIN; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; FLT1 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; BLOOD; FEMALE; HUMAN; PHYSIOLOGY; PLACENTA; PREECLAMPSIA; PREGNANCY; PRENATAL DEVELOPMENT; REVIEW; VASCULARIZATION;

ANGIOGENIC PROTEINS; ANTIGENS, CD; FEMALE; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; RECEPTORS, CELL SURFACE; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 34250372389     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2241     Document Type: Review

References (63)

1. Walker J. J: Pre-eclampsia. Lancet 356, 1260-1265 (2000)
2. Roberts J. M. & D. W. Cooper: Pathogenesis and genetics of pre-eclampsia. Lancet 357, 53-56 (2001) (Pubitemid 32056505)
3. Roberts J. M: Preeclampsia: what we know and what we do not know. Semin Perinatol 24, 24-28 (2000) (Pubitemid 30115266)
4. Page E. W: The relation between hydatid moles, relative ischemia of the gravid uterus and the placental origin of eclampsia. Am J Obstet Gynecol 37, 291-293 (1939)
5. Roberts J. M: Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 16, 5-15 (1998) (Pubitemid 28285299)
6. Maynard S. E, J. Y. Min, J. Merchan, K. H. Lim, J. Li, S. Mondal, T. A. Libermann, J. P. Morgan, F. W. Selke, I. E. Stilman, F. H. Epstein, V. P. Sukhatme & S. A. Karumanchi: Excess soluble fms-like tyrosine kinase may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111, 649-658 (2003) (Pubitemid 36278583)
7. Lam C, K. H. Lim & S. A. Karumanchi: Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension 46, 1077-1085 (2005) (Pubitemid 41533005)
8. Demir R, P. Kaufmann, M. Castelucci, T. Erbengi & A. Kotowski: Fetal vasculogenesis and angiogenesis in human placental villi. Acta Anat, Basel 136, 190-203 (1989) (Pubitemid 20045105)
9. Ahmed A. S, X. F. Li, C. E. Dunk, M. J. Whittle & T. Rollason: Colocalisation of vascular endothelial growth factor and its flt-1 receptor in human placenta. Growth Factors 12, 235-243 (1995)
10. Ahmed A, C. Dunk, S. Ahmad & A. Khaliq: Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PlGF) and soluble Flt-1 by oxygena review. Placenta 21 Suppl A, S16-S24 (2000)
11. Khaliq A, X. F. Li, M. Shams, P. Sisi, C. A. Acevedo, M. J. Whittle, H. Weich & A. Ahmed: Localisation of placenta growth factor (PlGF) in human term placenta. Growth Factors 13, 243-250 (1996) (Pubitemid 26378943)
12. Vuorela P, E. Hatva, A. Lymboussaki, A. Kaipainen, V. Joukov, M. G. Persico, K. Alitalo & E. Halmesmaki: Expression of vascular endothelial growth factor and placenta growth factor in human placenta. Biol Reprod 56, 489-494 (1997) (Pubitemid 27081593)
13. Smith S. K, Y. He, D. E. Clark & D. S. Charnock-Jones: Angiogenic growth factor expression in placenta. Semin Perinatol 24, 82-86 (2000) (Pubitemid 30115279)
14. Bussolati B, C. Dunk, M. Grohman, C. D. Kontos, J. Mason & A. Ahmed: Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factormediated angiogenesis via nitric oxide. Am J Pathol 159, 993-1008 (2001) (Pubitemid 32847190)
15. Ahmad S & A. Ahmed: Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res 95, 884-891 (2004) (Pubitemid 39435003)
16. Fong G. H, J. Rossant, M. Gertsenstein & M. L. Breitman: Role of the Flt-1 receptor tyrosine kinase in regulating assembly of vascular endothelium. Nature 376, 66-70 (1995)
17. Shalaby F, J. Rossant, T. P. Yamaguchi, M. Gertsenstein, X. F. Wu, M. L. Breitman, & A. C. Schuh: Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62-66 (1995)
18. Benirschke K & P. Kauffman: Pathology of the Human Placenta. London: Springer-Verlag
19. Zhou Y, S. J. Fisher, M. Janatpour, O. Genbacev, E. Dejana, M. Wheelock & C. H. Damsky. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Clin Invest 99, 2139-2151 (1997) (Pubitemid 27203770)
20. Pijnenborg R: Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy. Placenta 4, 397-414 (1983)
21. Burrows T. D, A. King & Y. W. Loke: Trophoblast migration during human implantation. Hum Reprod Update 2, 307-321 (1996)
22. Kam E. P., L. Gardner, Y. W. Loke & A. King: The role of trophoblast in the physiological change in decidual spiral arteries. Hum Reprod 14, 2131-2138 (1999) (Pubitemid 29381258)
23. Jauniaux E, A. L. Watson, J. Hempstock, Y. P. Bao, J. N. Skepper & G. J. Burton: Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure. Am J Pathol 157, 2111-2122 (2000)
24. Jauniaux E, J. Hempstock, N. Greenwold & G. J. Burton: Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies. Am J Pathol 162, 115-125 (2003) (Pubitemid 36041994)
25. Brosens I. A, W. B. Robertson & H. G. Dixon: The role of spiral arteries in the pathogenesis of pre-eclampsia. In: Obstetrics and gynecology annual vol. 1. New York: Appleton-Century-Crofts 1972
26. Gerretsen G, H. J. Huisjes & J. D. Elema: Morphological changes of the spiral arteries in the placental bed in relation to pre-eclampsia and fetal growth retardation. Br J Obstet Gynecol 88, 876-881 (1981) (Pubitemid 11018178)
27. Meekins J. W, R. Pijnenborg, M. Hanssens, I. R. McFayden & A. van Asshe: A study of placental bed spiral arteries and trophoblast invasion in normal and severe preeclamptic pregnancies. Br J Obstet Gynecol 101, 669-674 (1994) (Pubitemid 24251519)
28. Robertson W. B, I. A. Brosens & H. G. Dixon: The pathological response of the vessels of the placental bed to hypertensive pregnancy. J Pathol Bacteriol 93, 581-592 (1967)
29. Zhou Y, C. H. Damsky & S. J. Fisher: Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest 99, 2152-2164 (1997) (Pubitemid 27203771)
30. Zhou Y, C. H. Damsky, K. Chiu, J. M. Roberts & S. J. Fisher: Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts,. J Clin Invest 91, 950-960 (1993) (Pubitemid 23095269)
31. Hustin J, E. Jauniaux & J. P. Schaaps: Histological study of the materno-embryonic interface in spontaneous abortions. Placenta 11, 477-486 (1990)
32. Soleymanlou N, I. Jurisica, O. Nevo, F. Ietta, X. Zhang, S. Zamudio, M. Post & I. Caniggia: Molecular evidence of placental hypoxia in preeclampsia. J Clin Endocrinol Metabol 90, 4299-4308 (2005) (Pubitemid 41058212)
33. Shore V. H, T-H Wang, C-L Wang, R. J. Torry, M. R. Caudle & D. S. Torry: Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta 18, 657-665 (1997) (Pubitemid 27448423)
34. Chung J. Y, Y. Song, Y. Wang, R. R. Magness & J. Zheng: Differential expression of vascular endothelial growth factor (VEGF), endocrine gland derived-VEGF, and VEGF receptors in human placentas from normal and preeclamptic pregnancies. J Clin Endocrinol Metab 89, 2484-2490 (2004) (Pubitemid 38619893)
35. Dekker G. A: Risk factors for preeclampsia. Clin Obstet Gynecol 42, 422-435 (1999) (Pubitemid 30017267)
36. Zhou Y, M. McMaster, K. Woo, J. Perry, T. Karpanen, K. Alitalo, C. Damsky & S. J. Fisher: Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymers, and low platelets syndrome. Am J Pathol 160, 1405-1423 (2002) (Pubitemid 34411644)
37. Levine R. J, S. E. Maynard, C. Qian, K. H. Lim, L. J. England, K. F. Yu, E. F. Schisterman, R. Thadhani, B. P. Sachs, F. H. Epstein, B. M. Sibai, V. P. Sukhatme & S. A. Karumanchi: Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350, 672-683 (2004) (Pubitemid 38364626)
38. Venketesha S, M. Toporsian, C. Lam, J. Hanai, T. Mammoto, Y. M. Kim, Y. Bdolah, K. H. Lim, H. T. Yuan, T. A. Libermann, I. E. Stillman, D. Roberts, P. A. D'Amore, F. H. Epstein, F. W. Sellke, R. Romero, V. P. Sukhatme, M. Letarte & S. A. Karumanchi: Soluble endoglin contributes to the pathogenesis of preeclampsia. Nature Med 12, 642-649 (2006) (Pubitemid 43865232)
39. Shibata E, A. Rajakumar, R. W. Powers, R. W. Larkin, C. Gilmour, L. M. Bodnar, W. R. Crombleholme, R. B. Ness, J. M. Roberts & C. A. Hubel: Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. J Clin Endocrinol Metab 90, 4895-4903 (2005) (Pubitemid 41159388)
40. Torry D. S, H. S. Wang, T. H. Wang, M. R. Caudle & R. J. Torry: Preeclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol 179, 1539-1544 (1998) (Pubitemid 29028397)
41. Livingston J. C, R. Chin, B. Haddad, E. T. McKinney, R. Ahokas & B. M. Sibai: Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia. Am J Obstet Gynecol 183, 1554-1557 (2000) (Pubitemid 32061224)
42. Eremina V., M. Sood, J. Haigh, A. Nagy, G. Lajoie, N. Ferrara, H. P. Gerber, Y. Kikkawa, J. H. Miner & S. E. Quaggin: Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 111, 707-716 (2003) (Pubitemid 36278589)
43. McKeeman G. C, J. E. Ardill, C. M. Caldwell, A. J. Hunter & N. McClure: Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop. Am J Obstet Gynecol 191, 1240-1246 (2004) (Pubitemid 39421577)
44. Chaiworapongsa T, R. Romero, Y. M. Kim, G. J. Kim, M. R. Kim, J. Espinoza, E. Bujold, L. Goncalves, R. Gomez, S. Edwin & M. Mazor: Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia. J Matern Fetal Neonatal Med 17, 3-18 (2005) (Pubitemid 40515938)
45. Maglione D, V. Guerriero, G. Viglietto, P. Delli-Bovi & M. G. Persico: Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 88, 9267-9271 (1991) (Pubitemid 21915612)
46. Hauser S & H. A. Weich: A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta. Growth Factors 9, 259-268 (1993) (Pubitemid 24034347)
47. Maglione D, V. Guerriero, G. Viglietto, M. G. Ferraro, O. Aprelikova, K. Alitalo, S. Del Vecchio, K. J. Lei, J. Y. Chou & M. G. Persico: Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14. Oncogene 8, 925-931 (1993) (Pubitemid 23087424)
48. Ziche M, D. Maglione, D. Ribatti, L. Morbidelli, C. T. Lago, M. Battisti, I. Paoletti, A. Barra, M. Tucci, G. Parise, V. Vincenti, H. J. Granger, G. Viglietto & M. G. Persico: Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic. Lab Invest 76, 517-531 (1997) (Pubitemid 27176106)
49. Khaliq A, C. Dunk, J. Jiang, M. Shams, X. F. Li, C. Acevedo, H. Weich, M. Whittle & A. Ahmed: Hypoxia down-regulates placenta growth factor, whereas fetal growth restrictions up-regulates placenta growth factor expression: molecular evidence for "placental hyperoxia" in intratuterine growth restriction. Lab Invest 79, 151-170 (1999) (Pubitemid 29110646)
50. Desai J, V. Holt-Shore, R. J. Torry, M. R. Caudle & D. S. Torry: Signal transduction and biological function of placenta growth factor in primary human trophoblast. Biol Reprod 60, 887-892 (1999) (Pubitemid 29149373)
51. Torry D. S, H. S. Wang, T. H. Wang, M. R. Caudle & R. J. Torry: Pre-eclampsia is associated with reduced levels of placenta growth factor. Am J Obstet Gynecol 179, 1539-1544 (1998) (Pubitemid 29028397)
52. Thadhani R, W. P. Mutter, M. Wolf, R. J. Levine, R. N. Taylor, V. P. Sukhatme, J. Ecker & S. A. Karumanchi: First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab 89, 770-775 (2004) (Pubitemid 38269892)
53. Levine R. J, R. Thadhani, C. Qian, C. Lam, K. H. Lim, K. F. Yu, A. L. Blink, B. P. Sachs, F. H. Epstein, B. M. Sibai, V. P. Sukhatme & S. A. Karumanchi: Urinary placental growth factor and risk of preeclampsia. JAMA 293, 77-85 (2005) (Pubitemid 40066702)
54. Bersinger N. A & R. A. Odegard: Second and thirdtrimester serum levels of placental proteins in preeclampsia and small-for-gestational-age pregnancies. Acta Obstet Gynecol Scand 83, 37-45 (2004) (Pubitemid 38121729)
55. Taylor R. N, J. Grimwood, R. S. Taylor, M. T. McMaster, S. J. Fisher & R. A. North: Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol 188; 177-183 (2003)
56. Chappell L. C, P. T. Seed, A. Briley, F. J. Kelly, B. J. Hunt, S. Charnock-Jones, A. I. Mallet & L. Poston: A longitudinal study of biochemical variables in women at risk for preeclampsia. Am J Obstet Gynecol 187, 127-136 (2002) (Pubitemid 34800311)
57. St-Jacques S, M. Forte, S. J. Lye & M. Letarte: Localization of endoglinm a transforming growth factorbeta binding protein, and of CD44 and integrins in placenta during the first trimester of pregnancy. Biol Reprod 51, 405-413 (1994) (Pubitemid 24297612)
58. Cheifetz S, T. Bellon, C. Cales, S. Vera, C. Bernabeu, J. Massaque & M. Letarte: Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J Biol Chem 267, 19027-19030 (1992)
59. Gougos A, S. St-Jacques, A. Greaves, P. J. O'Connell, A. J. d'Apice, H. J. Buhring, C. Bernabeu, J. A. van Mourik & M. Letarte: Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts. Int Immunol 4, 83-92 (1992)
60. Letamendia A, P. Lastres, N. Almendro, U. Raab, H. J. Buhring, S. Kumar & C. Bernabeu: Endoglin, a component of the TGF-beta receptor system, is a differentiation marker of human choriocarcinoma cells. Int J Cancer 76, 541-546 (1998) (Pubitemid 28227998)
61. Caniggia I, C. V. Taylor, J. W. Ritchie, S. J. Lye & M. Letarte: Endoglin regulates trophoblast differentiation along the invasive pathway in human placental villous explants. Endocrinology 138, 4977-4988 (1997) (Pubitemid 27460938)
62. Tseng J. J, M. M. Chou, Y. T. Hsieh, M. C. Wen, E. S. Ho & S. L. Hsu: Differential expression of vascular endothelial growth factor, placenta growth factor and their receptors in placentae from pregnancies complicated by placenta accrete. Placenta 27, 70-78 (2006) (Pubitemid 41662882)
63. Bdolah Y, V. P. Sukhatme & S. A. Karumanchi: Angiogenic imbalance in the pathogenesis of preeclampsia: Newer Insights. Semin Nephrol 24:548-556 (2004) (Pubitemid 39505044)